Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,210 total articles
EquipmentShare.com Inc reported robust second quarter 2026 financial results highlighted by total revenue of $1.449 billion, a 26% increase year-over-year, driven by a 39% rise in rental segment revenue and strong operating income growth. Net income rose to $19 million and adjusted net income to $43 million for the quarter. The company added 23 new…
Genco Shipping & Trading Limited has taken delivery of the Genco Volunteer, a high-specification 182,000 dwt scrubber-fitted Capesize vessel, further expanding its premium fleet. Since late 2023, the company has invested over $400 million in seven modern Capesize and Newcastlemax vessels, generating approximately 30% internal rate of return. With a…
Lulu’s Fashion Lounge Holdings, Inc. (Nasdaq: LVLU) announced its Q2 2026 results, highlighting margin expansion, improved profitability, and positive Adjusted EBITDA. Despite a 17% revenue decline year-over-year, Lulus achieved its highest second-quarter gross margin since 2021 at 48.6%, reduced net loss by $1.5 million, increased wholesale revenu…
Marchex, Inc. announced its Q2 2026 financial results, reporting $11.0 million in revenue with a net loss of $0.4 million. Adjusted EBITDA showed improvement, especially on a pro forma combined basis with newly acquired Archenia. The acquisition closed on July 1, 2026, and aims to expand Marchex's conversational intelligence capabilities by integra…
Omega Flex, Inc. announced its second quarter 2026 financial results showing a decrease in net sales and net income compared to the prior year due to lower sales volumes and rising raw material costs. The company introduced a new re-engineered flexible gas piping fitting to enhance its residential and commercial market offerings. Additionally, the …
Bio Green Med Solution, Inc. announced its second quarter 2026 financial results highlighting improved net loss and fire safety product revenues. The company entered into a Business Combination Agreement to acquire Future NRG, which will make Future NRG its wholly owned subsidiary subject to closing conditions. The company raised approximately $0.8…
Fossil Group, Inc. reported Q2 2026 net sales of $210 million, down 4.9% year-over-year, primarily due to store rationalization impacting direct-to-consumer sales. The company improved gross margin by 490 basis points to 62.4%, driven by full price selling, sourcing initiatives, and reduced tariffs. Operating income was $3 million with adjustments …
First Tracks Biotherapeutics announced its second quarter 2026 financial results and business update highlighting progress in its Phase 1b clinical trials of ANB033 for celiac disease and eosinophilic esophagitis. The company received FDA Fast Track designation for ANB033 in celiac disease, expects to report top-line data from key cohorts in late 2…
Big Digital Energy, Inc. reported a 28% quarter-over-quarter revenue increase to $6.2 million in Q2 2026, driven by strong energy management and digital colocation revenues. The company expanded its energized capacity to approximately 129 MW, including acquisitions in Hood County and Cleburne, Texas. Strategic partnerships, such as a joint venture …
Leslie’s, Inc., the largest direct-to-customer pool and spa care brand in the U.S., announced its fiscal Q3 2026 results showing an 8.4% decrease in sales and a 15.5% drop in gross profit versus the prior year. While net income improved in Q3, nine-month results show a worsening net loss. The company is pursuing strategic alternatives including pot…
AEON Biopharma reported Q2 2026 financial results, highlighting progression in its ABP-450 biosimilar program targeting full-label U.S. therapeutic market entry as a Botox biosimilar. The company secured $15.3 million in financing with potential for an additional $34 million via milestone warrants, supporting operations through early 2027. FDA feed…
DeFi Development Corp. disclosed a 24% year-over-year increase in SOL per share, reaching 0.066 as of August 12, 2026. The company announced operational efficiencies to reduce costs in Q3 and beyond, repurchased convertible notes at a discount to simplify capital structure, and reaffirmed its long-term target to achieve 1.0 SOL per share by Decembe…
Ryman Hospitality Properties, Inc. announced the successful closing of an underwritten common stock offering totaling 5,865,000 shares priced at $117 each, including full exercise of the underwriters' over-allotment option, raising net proceeds of approximately $658 million. The proceeds will be contributed to RHP Hotel Properties, LP to fund a por…
Dillard's, Inc. plans to release its second quarter and year-to-date financial results for the 13 and 26 weeks ended August 1, 2026. The announcement will occur before the opening of the New York Stock Exchange.
Energous Corporation announced strong financial results for Q2 2026, posting $3.1 million in revenue, a 217% increase year-over-year, marking its sixth consecutive quarter of revenue growth. The company secured FCC certification for its PowerBridge Pro+ product, enabling commercialization of its end-to-end wireless power solution for ambient IoT de…
Aptera Motors reported its Q2 and H1 2026 financial results, highlighting key operational progress including obtaining EPA certification for its 2026 Launch Edition vehicle and placing orders for the first 40 production vehicles. The company raised approximately $24.6 million in gross capital year-to-date and secured additional funding subsequent t…
Royalty Pharma has entered into a funding agreement with Zealand Pharma, providing $100 million in exchange for economic rights to rusfertide, a potential first-in-class therapy for polycythemia vera. The funding supports Zealand Pharma's pipeline and accelerates the drug's progression through regulatory review, with a US FDA decision expected in Q…
Gaxos.ai Inc. announced record second-quarter revenue of $2.46 million, a 35.8% sequential increase and a 1,337% year-over-year surge. The company improved its marketing efficiency by increasing revenue generated per advertising dollar by approximately 20%. Gaxos completed the sale of its gaming assets, focusing on AI applications in consumer and e…
John B. Sanfilippo & Son, Inc., a leading processor and distributor of snack and recipe nut products, will release its fourth quarter fiscal 2026 operating results after the market close on August 19, 2026, followed by a conference call on August 20, 2026 at 10:00 a.m. ET to discuss the results. The company operates multiple nut and dried fruit sna…
Toppoint Holdings Inc. reported a 17% year-over-year revenue increase to $4.6 million in Q2 2026, an 80% reduction in net loss to $306,711, and a return to positive gross margin of 8%, driven by a strategic shift toward higher-value import and metal loads and price increases. The company completed a $4.15 million private placement, strengthened its…
MaxCyte, Inc. reported Q2 2026 total revenue of $7.3 million, with a net loss of $8.9 million, showing improvement from the prior year. The company reiterated its full-year 2026 revenue guidance of $30-32 million and highlighted a strategic multi-platform technology license partnership with Genentech announced post-quarter. Operating expenses decre…
Aligos Therapeutics announced the successful dosing of the first participant in the Phase 1 clinical trial of ALG-170675, a next-generation antisense oligonucleotide aimed at functional cure for chronic hepatitis B virus infection. The study is being conducted in China by their partner Amoytop, who holds rights in Greater China. ALG-170675 has demo…
Acrivon Therapeutics, a clinical-stage biotech company, announced its Q2 2026 financial results, highlighted progress in its lead clinical programs ACR-368 and ACR-2316 targeting endometrial and lung cancers, respectively, and provided upcoming milestones including interim data readouts and initiation of Phase 3 trials. The company also strengthene…
Connect Biopharma Holdings Limited reported financial results for Q2 2026, highlighted by completion of enrollment in Phase 2 Seabreeze STAT trials assessing rademikibart for acute exacerbations in asthma and COPD. Topline data are expected in September 2026, which will inform potential Phase 3 trial design. The company has a cash runway of at leas…
Core Molding Technologies, a leading engineered materials company specializing in molded structural products for various industries, announced an investor day event on September 29-30, 2026, including presentations and a tour of its large manufacturing facility in Matamoros, Mexico. Management will discuss growth opportunities, operational excellen…
